- Home
- DOV vs BNTX Comparison
DOV vs BNTX Comparison
Compare DOV & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOV
- BNTX
- Stock Information
- Founded
- DOV 1947
- BNTX 2008
- Country
- DOV United States
- BNTX Germany
- Employees
- DOV N/A
- BNTX N/A
- Industry
- DOV Industrial Machinery/Components
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DOV Industrials
- BNTX Health Care
- Exchange
- DOV Nasdaq
- BNTX Nasdaq
- Market Cap
- DOV 23.7B
- BNTX 25.0B
- IPO Year
- DOV N/A
- BNTX 2019
- Fundamental
- Price
- DOV $174.81
- BNTX $106.53
- Analyst Decision
- DOV Buy
- BNTX Strong Buy
- Analyst Count
- DOV 12
- BNTX 18
- Target Price
- DOV $208.58
- BNTX $141.55
- AVG Volume (30 Days)
- DOV 858.7K
- BNTX 1.2M
- Earning Date
- DOV 07-24-2025
- BNTX 08-04-2025
- Dividend Yield
- DOV 1.18%
- BNTX N/A
- EPS Growth
- DOV 59.80
- BNTX N/A
- EPS
- DOV 16.60
- BNTX N/A
- Revenue
- DOV $7,728,249,000.00
- BNTX $2,968,331,171.00
- Revenue This Year
- DOV $4.08
- BNTX N/A
- Revenue Next Year
- DOV $4.64
- BNTX $10.68
- P/E Ratio
- DOV $10.52
- BNTX N/A
- Revenue Growth
- DOV 3.19
- BNTX 0.61
- 52 Week Low
- DOV $143.04
- BNTX $76.53
- 52 Week High
- DOV $222.31
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- DOV 43.78
- BNTX 54.09
- Support Level
- DOV $175.81
- BNTX $102.24
- Resistance Level
- DOV $180.75
- BNTX $108.56
- Average True Range (ATR)
- DOV 2.85
- BNTX 4.00
- MACD
- DOV -0.71
- BNTX -0.35
- Stochastic Oscillator
- DOV 13.19
- BNTX 20.76
About DOV Dover Corporation
Founded in 1955 by George Ohrstrom, Dover has become an industrial behemoth through the acquisition of dozens of esteemed brands. The company is organized into five segments through which it designs and manufactures highly engineered components, such as vehicle repair, factory automation, welding, aerospace, fuel dispensing, printing, liquid handling, refrigeration, and can-making equipment. It has operations around the globe but generates over half of its revenue in the United States.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.